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Anatomy and Function of Autonomic 
Innervation of the Liver
By: Kennan Negrete
Faculty Mentor: Dr. Zixi Cheng
UCF School of Biomedical Sciences
ABSTRACT: The liver is one of the most important regulatory organs, and its extensive influence upon homeostatic 
balance is well-documented. However, the role of autonomic innervation in the control and regulation of hepatic 
function is poorly understood relative to the other organs of the digestive system. Furthermore, the neuroanatomical 
layout of the liver remains an incomplete puzzle with various missing pieces. The scarcity of information concerning 
such a critical organ presents an interesting conundrum for the scientific and biomedical communities alike, especially 
given the prevalence of liver degeneracy and disease in the modern clinical setting. A more complete understanding of 
the precise anatomy of hepatic autonomic innervation, as well as the role it plays in both the normal function and 
diseased state of the organ, could aid in the development of novel and improved treatments for various debilitating and 
potentially lethal conditions. The purpose of this review is to compile the breadth of knowledge regarding hepatic 
autonomic innervation, to discuss the limitations of previous research, and to suggest future directions for a field that 
shows great potential for continued advancement.
KEYWORDS: liver; autonomic innervation; hepatic innervation
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INTRODUCTION
The liver is a key regulatory organ of both glucose and 
lipid metabolism, and various studies have shown that 
autonomic innervation plays a role in the regulation of 
hepatic function (Akiyoshi, Gonda, & Terada, 1998; 
Berthoud, 2004; Kalsbeek et al., 2010; McCuskey, 2004; 
Perez-Tilve et al., 2010; Tunderaher, Farr, & Adeli, 
2017; Verma, Antony, Ogunnaike, Hoek, & Vadigepalli, 
2018; Yi, la Fleur, Fliers, & Kalsbeek, 2010). This 
liver-brain axis is under-studied, with many unknowns 
regarding its structure, function, and scope (Akiyoshi 
et al., 1998; Berthoud, 2004; Kalsbeek et al., 2010; 
McCuskey, 2004; Perez-Tilve et al., 2010; Taher et al., 
2017; Verma et al., 2018; Yi et al., 2010). Additionally, in 
liver transplant cases, autonomic innervation of hepatic 
tissue is significantly reduced, yet the liver continues to 
function at a level that deviates only moderately from 
normal (Tiniakos, Lee, & Burt, 1996; Yi et al., 2010). 
The study of the liver-brain axis is further complicated 
by large anatomical differences in nerve distribution 
between rodents and higher mammals, particularly in 
the parenchyma (Akiyoshi et al., 1998; McCuskey, 2004; 
Verma et al., 2018). Despite these obstacles, the study 
of the neural map of the liver provides a link between 
the organ’s many functions and the influence of the 
autonomic nervous system. 
This review summarizes knowledge concerning the form 
and function of hepatic sensory and motor innervation 
acquired over the last five decades. Among the topics 
covered are the anatomical neural map of the rodent liver, 
which notably lacks intrahepatic ganglia (Berthoud, 2004; 
Berthoud and Neuhuber, 2000; Taher et al., 2017), as well 
as the influence of the sympathetic and parasympathetic 
nervous system upon various metabolic and regulatory 
pathways. While substantial evidence implicates the 
hypothalamus and autonomic nervous system in various 
modifications of liver activity, the precise mechanisms 
and interplay of the nervous, endocrine, and hepatic 
systems have yet to be fully elucidated.  Understanding 
of the liver-brain axis is still far from complete, but 
technological advances may allow many of the topics 
covered here to be revisited and explored in far greater 
depth than was previously possible. These advances, in 
turn, could potentially lead to the discovery of novel, 
neural-based treatments for chronic liver disease.
BACKGROUND
The Neural Map of the Rat Liver
This discussion begins with analysis of the rat liver, the 
most well-studied of the mammalian livers. Although 
it provides the most complete picture of the anatomical 
layout and physiological role of autonomic innervation 
in the hepatic setting, the rat liver is far from the level of 
completion seen in the rest of the gastrointestinal tract. 
Despite these shortcomings, several major populations 
of neurons travelling between the sympathetic and 
parasympathetic centers and hepatic tissues have been 
identified. Sympathetic afferent innervation travels 
through the dorsal root ganglia to the dorsal gray horn of 
the spinal cord (Baik et al., 2017; Gardemann, Puschel, 
& Jungermann, 1992; Jensen, Alpini, & Glaser, 2013; 
Taher et al., 2017; Tiniakos et al., 1996). Vagal afferent 
innervation reaches the nucleus of the solitary tract via 
the nodose ganglion (Baik et al., 2017; Gardemann et 
al., 1992; Jensen et al., 2013; Taher et al., 2017; Tiniakos 
et al., 1996). Efferent innervation of the liver is achieved 
via two major motor plexuses. The anterior plexus is 
located at the hilum alongside the hepatic artery, while 
the posterior plexus is found near the portal vein and bile 
duct system (Baik et al., 2017; Gardemann et al., 1992; 
Jensen et al., 2013; Reilly, McCuskey, & McCuskey, 
1978; Taher et al., 2017; Tiniakos et al., 1996). These 
plexuses carry parasympathetic fibers originating from 
the vagus, especially the dorsal motor nucleus (Baik et 
al., 2017; Gardemann et al., 1992; Jensen et al., 2013; 
Taher et al., 2017; Tiniakos et al., 1996). Intrahepatic 
ganglia, however, have not been found, with only nearby 
paraganglia displaying vagal innervation (Berthoud, 
2004; Berthoud & Neuhuber, 2000; Taher et al., 2017). 
This omission is highly unusual for a major organ and 
presents a challenge for future studies that attempt 
to locate these missing ganglia. Sympathetic efferent 
neurons also innervate the liver, originating in the 
intermediolateral spinal column and passing through the 
celiac and superior mesenteric prevertebral ganglia (Baik 
et al., 2017; Gardemann et al., 1992; Jensen et al., 2013; 
Taher et al., 2017). Figure 1, seen below, gives a visual 
representation of the known paths between the Central 
Nervous System (CNS) and hepatic structures in the rat.
11.2: 18-31
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Vagal afferent innervation reaches the NTS via the 
nodose ganglion. Vagal efferent innervation originates in 
the paraventricular nucleus (PVN), passes through the 
dorsal motor nucleus, and reaches the paraganglia before 
terminating primarily in the portal triad. Sympathetic 
afferents innervate the vessels and bile ducts, carrying 
sensory information to the dorsal horn of the spinal cord 
through the dorsal root ganglia. Sympathetic efferent 
innervation comes from the PVN and synapses in the 
celiac and superior mesenteric ganglia. The arcuate 
nucleus (ARC) and suprachiasmatic nucleus (SCN) 
exert CNS influence over the PVN, impacting both 
sympathetic and parasympathetic responses. Intrahepatic 
ganglia have not been found (Baik et al., 2017; Berthoud, 
2004; Berthoud and Neuhuber, 2000; Gardemann et al., 
1992; Jensen et al., 2013; Reilly, McCuskey & McCuskey, 
1978; Taher et al., 2017; Tiniakos et al., 1996).
Afferent Tracing Techniques
Berthoud and others elucidated the afferent autonomic 
innervation of the rat liver using various tracing techniques. 
Retrograde and anterograde tracing methods have both 
been used to discover the origin and termination sites of 
vagal afferents (Berthoud, 2004; Kalsbeek et al., 2010). 
In the former, both horseradish peroxidase injections of 
the common hepatic branch of the vagus and True Blue 
injections of the hepatic artery and portal vein revealed 
fibers extending to the left nodose ganglion (Berthoud, 
2004). Additional horseradish peroxidase injections of 
the hilum and bile duct regions revealed innervation 
in the right nodose ganglion, which is unusual because 
these nerves do not connect to the common hepatic 
branch (Berthoud, 2004). Anterograde tracing has been 
accomplished with DiI injections, but these studies 
have revealed that most of the common hepatic branch 
descends to innervate other gastrointestinal structures, 
such as the duodenum (Berthoud, 2004). Calretinin and 
P2X2/X3 vesicular glutamate transporter both show 
promise as more specific tracers, but neither have been 
extensively applied to the hepatic setting (Berthoud, 
2004). Of the little innervation that reaches the liver 
proper, most is found around the bile ducts and portal 
triad (Akiyoshi et al., 1998; Berthoud, 2004; Kalsbeek 
et al., 2010). Neither technique has thus far revealed 
any hepatic vagal innervation in the rat parenchyma 
(Akiyoshi et al., 1998; Berthoud, 2004; Kalsbeek et al., 
2010; McCuskey, 2004; Verma et al., 2018).
Researchers have achieved tracing of the spinal dorsal 
root ganglionic afferents via the use of calcitonin-
gene-related peptide (CGRP) as a marker (Berthoud, 
2004). HRP injections into liver tissue near intrahepatic 
bile ducts detected the presence of this substance 
primarily around the bile ducts, with very little 
innervation of the parenchyma (Berthoud, 2004). 
11.2: 18-31
Figure 1: The origins and pathways of hepatic autonomic innervation in the rat liver.
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CGRP immunohistochemistry returned similar results 
(Akiyoshi et al., 1998; Berthoud, 2004).
Immunohistochemistry and Variability Between Species
Researchers have also used immunohistochemistry on 
other neuropeptide, neurotransmitter, and hormonal 
markers to map autonomic innervation in the livers 
of both rats and higher mammals. These studies have 
revealed more information regarding the innervation of 
the rat liver, but also how it differs from the innervation 
patterns in humans and other mammals such as the dog or 
guinea pig (Akiyoshi et al., 1998). Immunohistochemical 
techniques have revealed aminergic, peptidergic, and 
cholinergic innervation in the mammalian liver (Akiyoshi 
et al., 1998). The former two types of innervation were 
traced using various target substances, including tyrosine 
hydroxylase (TH), neuropeptide Y (NPY), substance P 
(SP), vasoactive intestinal polypeptide (VIP), calcitonin-
gene-related peptide (CGRP), and galanine (GAL) 
(Akiyoshi et al., 1998; Burt et al., 1989). These markers 
showed the greatest response surrounding the portal 
system and bile ducts in the rat liver (Akiyoshi et al., 
1998; Burt et al., 1989; McCuskey, 2004). Nevertheless, 
these forms of innervation were also present in all other 
species tested, indicating a highly conserved innervation 
pattern, at least in the case of these neurons (Akiyoshi et 
al., 1998; McCuskey, 2004). Acetylcholinesterase, used 
to indicate cholinergic innervation, gave a similar multi-
species response (Akiyoshi et al., 1998; McCuskey, 2004).
Higher mammals displayed TH, NPY, and SP 
innervation in the parenchyma of the liver, which is 
conspicuously absent in the livers of rats and other 
small rodents such as hamsters (Akiyoshi et al., 1998; 
Burt et al., 1989; Metz & Forssmann, 1980). Further 
confirmation of this trend has been provided by 
glyoxylic acid-paraformaldehyde fluorescent microscopy, 
especially of the guinea pig liver (Metz & Forssmann, 
1980). The tree shrew, a small primate, demonstrates 
extensive adrenergic innervation extending out from the 
triads and into the lobules themselves (Forssmann & Ito, 
1977). Researchers have theorized that this additional 
sympathetic innervation contributes to the function 
of larger livers (Azanza, Aisa, Junquera, & Castiella, 
1989). The innervation itself is mainly found along the 
spaces of Disse surrounding the fat storing stellate cells 
(Forssmann & Ito, 1977; McCuskey, 2004; Streba, Vere, 
Ionescu, Streba, & Rogoveanu, 2014). Further study of 
the parenchymal innervation of higher mammals in both 
normal and pathological settings is required for a better 
understanding of this phenomenon. A promising target 
for future immunohistochemical techniques is PGP 9∙5 
(Lee, Ahmed, Hines, & Burt, 1992). This is a neuronal 
axoplasmic protein expressed by parenchymal nerves and 
shows potential for reliable marking (Lee et al., 1992).
Interestingly, in species displaying interlobular 
innervation, neural penetration of the parenchyma 
occurs very late in development (Kandilis, Papadopoulou, 
Koskinas, Sotiropoulos, & Tiniakos, 2015). Unlike 
other organs of the gastrointestinal tract, the liver does 
not receive innervation from the neural crest (Kandilis 
et al., 2015). The liver remains poorly innervated until 
near term, with only portal innervation present (Kandilis 
et al., 2015). Researchers have speculated that because 
the liver is mainly involved in hematopoiesis for much 
of its fetal life, the additional regulatory innervation for 
metabolic function would be unnecessary (Kandilis et al., 
2015).
In rats and hamsters, portal innervation is believed to be 
the primary CNS control mechanism, a trait they share 
with less complex vertebrates such as frogs (Akiyoshi 
et al., 1998; Azanza et al., 1989; McCuskey, 2004). 
Where these small livers lack aminergic innervation in 
the parenchyma, gap junctions are found to propagate 
the electrical signal throughout the liver lobules (Beckh, 
Fuchs, Balle, & Jungermann, 1990; Jensen et al., 2013; 
McCuskey, 2004; Verma et al., 2018). Researchers 
have speculated that gap junctions and sympathetic 
innervation share an inverse relationship (Forssmann 
& Ito, 1977; McCuskey, 2004). Gap junctions in the rat 
liver consist of six connexin-32 units (Streba et al., 2014). 
Evidence for the function of these gap junctions is found 
in the propagation of intracellular Ca2+ responses, which 
requires non-unidirectional concentration gradients and 
cellular exchange (Verma et al., 2018). Ca2+ is vital for 
many functions of the liver, and monitoring of these 
responses in the live rodent model has revealed that they 
travel in a wavelike motion from the pericentral region 
(PC) region of the liver lobule to the periportal region 
(PP) (Verma et al., 2018). The fact that this propagation 
is opposite the blood flow of the liver suggests that there 
is zonation, or organized differences in cell signaling, 
among hepatocytes (Sluka et al., 2016; Verma et al., 
2018). This zonation, however, is under-studied and not 
yet fully understood (Verma et al., 2018).
Challenges with Denervation Studies
While structural mapping of the rat liver has produced 
both successes and challenges, functional mapping of the 
11.2: 18-31
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liver may prove even more puzzling. The issues primarily 
arise from the close association of hepatic innervation 
to that of other areas of the gastrointestinal tract, as 
well as the difficulty in differentiating between varieties 
of hepatic afferents and efferents (Berthoud, 2004; 
Yi et al., 2010). Selective vagotomies, for example, are 
nearly impossible because the common hepatic branch 
of the vagus also innervates the duodenum, and any 
physiological changes that occur cannot necessarily be 
isolated to a hepatic cause (Berthoud, 2004). The use 
of this technique is therefore limited in reliability, but 
has been proven effective in the study of sympathetic 
efferent using toluidine blue labelling and pseudorabies 
virus (Berthoud, 2004). Selective vagal deafferentation 
and defferentation are also impractical methods in that 
the two types of fibers are extremely difficult, if not 
impossible, to separate. (Berthoud, 2004; Yi et al., 2010). 
Most afferent fibers elsewhere in the body are reliably 
denervated by treatment with capsaicin, which binds 
vanilloid receptors and triggers apoptosis (Berthoud, 
2004). Hepatic vagal afferents, however, do not always 
respond to capsaicin treatment and thus there is no 
way of knowing if the deafferentation procedure was 
successful (Berthoud, 2004; Yi et al., 2010).
Selective sympathectomies and spinal deafferentation 
share similar issues, especially unwanted damage to 
nearby vagal pathways (Berthoud, 2004; Yi et al., 
2010). Capsaicin is again an unreliable treatment, as 
spinal afferents run alongside other unrelated neurons 
in their journey to the dorsal root ganglia (Berthoud, 
2004). Therefore, the effects of a supposed “spinal 
deafferentation” could be attributed to various other 
forms of neural damage and separate effector organ 
pathways. As previously mentioned, some successful 
studies of sympathetic innervation were carried out with 
toluidine blue and pseudorabies virus, but since only 
one such procedure has been performed successfully, the 
applications are extremely limited in scope (Berthoud, 
2004).
In advanced species, interlobular innervation has been 
targeted with 6-OH dopamine (Burt et al., 1989; 
Forssmann & Ito, 1977). However, this technique is as 
unreliable as its counterparts, because it does not degrade 
all nerve fibers in the parenchyma, with only some fibers 
breaking down to myelin bodies (Forssmann & Ito, 
1977). Furthermore, the denervation is not permanent, 
regenerating within 60-90 days (Forssmann & Ito, 1977).
The extreme difficulties in functional mapping of the 
hepatic system should be considered when discussing the 
specific functions of CNS innervation (Berthoud, 2004; 
Kalsbeek et al., 2010). While there is a general agreement 
as to the regulatory functions of many pathways, much of 
the CNS role in liver function is poorly understood, and 
knowledge is still evolving. Until more accurate methods 
of isolating liver innervation are discovered, there will 
most likely be a good deal of nervous function that 
remains under-studied.
The Hypothalamus: The Primary Brain-Liver Integration 
Center
The primary integration center of the liver, as with most 
organs under autonomic regulation, is the hypothalamus 
(Kalsbeek et al., 2010; Taher et al., 2017; Yi et al., 2010). 
This key regulatory center of the brain directly influences 
both lipid and glucose metabolism (Kalsbeek et al., 
2010; Taher et al., 2017; Yi et al., 2010). The former 
process is controlled by the orexigenic and anorexigenic 
populations of the arcuate nucleus (ARC) that mediate 
very low-density lipoprotein (VLDL) production by 
the liver (Taher et al., 2017). The orexigenic populations 
secrete two neuropeptides that function antagonistically 
to one another (Taher et al., 2017). NPY increases 
hepatic VLDL production by stimulating the activity 
of stearoyl CoA reductase-1 (SCD-1), adenosine 
diphosphate (ADP) ribosylation factor-1 (ARF-1), and 
lipin-1, while galanine-like peptide (GALP) increases 
lipid metabolism by increasing the expression of the lipid 
transporters carnitine palmitoyl transferases (CTPs) I 
and II via sympathetic stimulation ( Jensen et al., 2013; 
Rojas et al., 2015; Taher et al., 2017). This is an unusual 
function for an orexigenic pathway, but its presence allows 
the orexigenic center to both up and down-regulate 
lipid metabolism (Taher et al., 2017). The anorexigenic 
populations secrete pro-opiomelanocortin, the basis of 
a key lipid pathway in the liver-brain axis (Perez-Tilve 
et al., 2010; Taher et al., 2017). Pro-opiomelanocortin 
(POMC) stimulates second-order neurons to produce 
melanocortins 3 and 4 (MC3/MC4) (Perez-Tilve et al., 
2010; Taher et al., 2017). Figure 2 provides a simplified 
version of the central melanocortin pathway. Blockage 
of this pathway reduces lipogenesis and high-density 
lipoprotein (HDL) uptake, and if left unchecked can 
lead to liver steatosis, the buildup of fat in liver tissue 
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This neural pathway is mostly responsible for 
anorexigenic regulation of lipid metabolism, although 
POMC populations also play a role in glucose 
regulation. Anorexigenic neurons in the ARC produce 
POMC, which stimulates second order neurons to 
produce melanocortins 3 and 4. These peptides promote 
lipogenesis and HDL uptake. The hormones ghrelin and 
glucagon-like peptide-1 can cross the blood brain barrier 
at the median eminence via specialized cells called 
tanycytes. These hormones have antagonistic functions, 
with glucagon-like peptide-1 stimulating the central 
melanocortin pathway and ghrelin serving an inhibitory 
function (Coll & Yeo, 2013; Kandilis et al., 2015; Perez-
Tilve et al., 2010; Taher et al., 2017).
Recent studies have shown that hormonal influences on 
the melanocortin pathway have a major impact on the 
concentration of high-density lipoprotein cholesterol 
(HDL-C) in the plasma (Perez-Tilve et al., 2010). 
These influences can be both up and down-regulatory, 
as indicated by the actions of ghrelin and glucagon-like 
peptide-1 (GLP-1) (See Figure 2, above) (Perez-Tilve 
et al., 2010). These hormones access the ARC through 
the median eminence, a region of the blood-brain barrier 
controlled by modified glial cells called tanycytes (Coll 
& Yeo, 2013). Ghrelin is an inhibitor of the central 
melanocortin pathway, and treatment with ghrelin 
leads to increased circulating HDL-C (Perez-Tilve 
et al., 2010). Glucagon-like-peptide is antagonistic to 
ghrelin and stimulates the central melanocortin pathway, 
lowering circulating HDL-C ( Jensen et al., 2013; Perez-
Tilve et al., 2010). These changes in plasma cholesterol 
occur without any associated changes in body weight 
in the rat model, even if the melanocortin receptors 
are destroyed or impaired (Perez-Tilve et al., 2010). 
Therefore, this pathway is likely responsible for HDL-C 
uptake rather than production (Perez-Tilve et al., 2010).
The hypothalamus is also involved in afferent lipid sensing, 
with the ability to reduce hepatic glucose production to 
prevent resting hyperglycemia (Pocai, Obici, Schwartz, 
& Rossetti, 2005). Central inhibition of fat oxidation 
stimulates the NTS and the dorsal motor nucleus to 
down-regulate gluconeogenesis and the construction 
of the associated enzymes, thereby lowering hepatic 
glucose production (Pocai et al., 2005). This pathway 
is mediated by ATP-dependent K+ channels (KATP), 
and may require an intact hepatic vagus, as severing 
this branch leads to resting hyperglycemia (Pocai et 
al., 2005). The ARC provides a second hypothalamic 
pathway for lipid sensing (Pocai et al., 2005). A decrease 
in CTP1 mitochondrial enzyme activity leads to a build-
up of long-chain fatty acyl-CoA (LC-CoA) (Pocai et al., 
2005). This build-up signals an abundance of nutrients 
that eventually shifts metabolism from carbohydrates to 
lipids and reduces hepatic glucose production (Pocai et 
11.2: 18-31
Figure 2: The central melanocortin pathway and the influence of hormones.
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increases circulating glucose levels and also reduces 
feeding behavior (Kalsbeek et al., 2010). This neuropeptide 
may have additional effects on the counterregulation of 
hypoglycemia and energy storage in the form of white 
adipose tissue (Kalsbeek et al., 2010). VIP has broad 
effects upon metabolism and feeding that may impact 
hepatic function (Kalsbeek et al., 2010).
The final three hypothalamic hormones discussed 
below have some glucose-related function, but their 
precise impacts and pathways remain ambiguous. The 
first is thyrotropin-releasing hormone (TRH), which 
can induce hyperglycemia, but its exact mechanism is 
unknown (Kalsbeek et al., 2010). Arginine-vasopressin 
(AVP) promotes hepatic glucose production via 
gluconeogenesis and glycogenolysis, and modifies insulin 
and glucagon release (Kalsbeek et al., 2010), but it has 
not been shown to directly impact glucose metabolism 
(Kalsbeek et al., 2010). This hormone is of interest due 
to its secondary effects on lipid metabolism (Kalsbeek et 
al., 2010). It can both up and down-regulate lipogenesis 
and lipogenolysis, creating a possible direct link between 
hypothalamic glucose and lipid metabolism (Kalsbeek 
et al., 2010). The final hormone, oxytocin, reduces food 
intake (Kalsbeek et al., 2010). An oxytocin-deficient 
model animal will become obese, but once again, there 
is no direct link between this function and hepatic 
glucose metabolism (Kalsbeek et al., 2010). These three 
hormones are not alone in ambiguity. In fact, a large 
quantity of PVN secretions have functions that remain 
unclear (Kalsbeek et al., 2010).
Neuro-endocrine Interplay in Hepatic Regulation
CNS control of hepatic glucose and lipid metabolism 
extends beyond the major hypothalamic pathways 
to include various endocrine and receptor-mediated 
pathways that aid in systemic regulation of circulating 
glucose levels and fat storage (Berthoud, 2004; Forssmann 
& Ito, 1977; Jensen et al., 2013; Mizuno & Ueno, 2017; 
Taher et al., 2017; Yi et al., 2010). Furthermore, these 
peripheral pathways appear to function semi-normally 
even without much of the liver-brain axis intact, as with 
liver transplant patients (Tiniakos et al., 1996; Yi et al., 
2010).
The liver contains various mechanisms for glucose 
sensing, neuronal monitoring of circulating glucose via 
glucokinase (GK) and glucose transporters (GLUT) 
( Jensen et al., 2013; Mizuno & Ueno, 2017; Yi et al., 
11.2: 18-31
al., 2005), while ARC action is signaled by an increase in 
C-Fos expression following CTP1 inhibition (Pocai et 
al., 2005). Neither this pathway nor the NTS mechanism 
seems to require vagal afferents to function, and KATP 
channels can be stimulated hormonally by leptin and 
insulin (Pocai et al., 2005).
The role of the hypothalamus in hepatic glucose 
metabolism is closely tied to its larger role in the 
circadian rhythms of the body, which are controlled by 
the suprachiasmatic nucleus (SCN) ( Jensen et al., 2013; 
Kalsbeek et al., 2010). This hypothalamic center has 
projections to both the sympathetic and parasympathetic 
periventricular nucleus (PVN), the integrating center 
responsible for CNS-mediated glucose regulation 
(Kalsbeek et al., 2010). The neuronal signals from the 
PVN take the form of various neuroendocrine and 
neuropeptide secretions (Kalsbeek et al., 2010).
Another proposed parasympathetic pathway for glucose 
regulation involves POMC, but there is a significant 
conflict in the data regarding this function (Kalsbeek 
et al., 2010). POMC neurons have been shown to 
respond to leptin, insulin, and serotonin (Coll & Yeo, 
2013; Smith, 2018). These hormones work in opposition 
of NPY to reduce hepatic glucose production. Central 
insulin increases hepatic insulin sensitivity to reduce 
gluconeogenesis (Coll & Yeo, 2013; Konig, Bulik, & 
Holzhutter, 2012; Smith, 2018). Unlike downstream 
melanocortin pathways, however, inhibition of this 
pathway does lead to obesity (Kalsbeek et al., 2010). 
Individuals who lack central insulin and leptin receptors, 
as well as those who lack 5-hydroxytryptamine 2C 
receptors (5-HT2CRs) for serotonin have an increased 
incidence of obesity and hyperphagia (Coll & Yeo, 
2013). Disruption of hypoxia-inducible factor (HIF) and 
cellular autophagy in POMC populations also leads to 
obesity (Coll & Yeo, 2013).
Other hormones and neuropeptides of the hypothalamus 
perform functions related to both feeding behavior and 
glucose metabolism, but since these are not always 
correlated with one another, each is considered a separate 
process (Kalsbeek et al., 2010). Orexin, for example, has 
ambiguous effects on obesity, but has been shown to 
increase hepatic glucose uptake (Kalsbeek et al., 2010). 
Melanin-concentrating hormone (MCH), while critical 
to the initiation of feeding behavior, does not appear to 
have any effect on glucose metabolism (Kalsbeek et al., 
2010). By contrast, pituitary adenylate cyclase activating 
peptide (PACAP), when administered to the brain, 
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2010). Liver receptor X (LRX) and carbohydrate response 
element-binding protein (ChREBP) are intrahepatic 
glucose monitors with unknown signaling pathways 
that may involve the autonomic nervous system (Yi et 
al., 2010). The former controls the secretion of adropin, 
which is a paracrine and endocrine mediator of glucose 
and lipid metabolism (Yi et al., 2010). Hepatic insulin-
sensitizing substance (HISS) is secreted by the liver 
following parasympathetic stimulation (Kandilis et al., 
2015; Yi et al., 2010). This substance also increases skeletal 
muscle glucose uptake (Yi et al., 2010). Parasympathetic 
denervation disrupts this pathway and can reduce total 
glucose disposal by as much as 50% (Kandilis et al., 2015). 
Interestingly, blockage of M3 cholinergic receptors did 
not lead to similar effects, indicating that the vagus may 
act through alternative pathways as opposed to direct 
acetylcholine stimulation (Kandilis et al., 2015). Central 
insulin can modify gluconeogenesis outright, though the 
mechanism is still largely ambiguous (Kimura et al., 2016). 
The pathway is thought to involve the disinhibition of 
IL-6 and STAT-3, both of which reduce the expression 
of gluconeogenic enzymes (Kimura et al., 2016). IL-6 
and STAT-3 are normally inhibited by vagal innervation 
of the α7-nicotinic cholinergic receptors (α7-nAchR) 
of Kupffer cells (Kimura et al., 2016). Central insulin 
detection leads to suppression of the vagus and release of 
these factors (Kimura et al., 2016). In obese and insulin-
resistant individuals, the vagal inhibition is less successful 
(Kimura et al., 2016).
The portal vein is primarily responsible for hepatic 
glucose sensing and is especially critical in responding 
to systemic hypoglycemia ( Jensen et al., 2013; Yi et al., 
2010). As a hypoglycemic state is often the result of 
fasting, portal sensors play a key role in initiating a feeding 
response ( Jensen et al., 2013; Yi et al., 2010). The portal 
response, however, does not appear to reduce food intake 
upon its inhibition and is incapable of detecting rapid-
onset hypoglycemia ( Jensen et al., 2013). A pathway 
involving neural-hormonal crosstalk and transcriptional 
regulation is simply too slow to respond in such a short 
time frame (Konig et al., 2012). Liver transplant patients 
have been shown to have a higher prevalence of systemic 
hypoglycemia due to a reduced counterregulatory portal 
response ( Jensen et al., 2013).
Lipid-sensing is another key function of the alternative 
liver pathways and has been shown to work closely 
with the gastrointestinal tract to maintain an optimal 
balance of free fatty acids (FFAs) in the blood ( Jensen 
et al., 2013; Mizuno & Ueno, 2017; Taher et al., 2017; 
Yi et al., 2010). An increase in FFAs either through diet 
or through enhanced lipolysis of abdominal adipose 
triggers a response in the hepatic vagus that increases 
general satiety, but if the increase in FFAs is too great, 
overstimulation can lead to insulin resistance and reduced 
insulin clearance (Yi et al., 2010). This pathway is likely 
mediated by peroxisome-proliferator-activator receptors 
(PPARs) in the liver (Yi et al., 2010). Insulin itself is also 
active in hepatic lipid sensing, with centralized insulin 
responses leading to decreased VLDL production and 
increased hepatic lipid storage, and peripheral insulin 
responses having an antagonistic function (Taher et 
al., 2017). In addition, insulin is often aided by leptin, 
which if deficient can lead to insulin resistance, and 
by adipokines, factors secreted by brown adipose tissue 
(BAT) (Kandilis et al., 2015; Taher et al., 2017).
In times of energy shortage, the liver can respond by 
secreting its own mediator of lipid metabolism, fibroblast 
growth factor-21 (FGF-21) (Berthoud, Munzberg, 
& Morrison, 2017; Clemmensen et al., 2017; Coll 
& Yeo, 2013). This hormone increases fat oxidation 
and ketogenesis to produce energy during crisis. 
This hormone also responds to glucagon and GLP-1 
stimulation (Clemmensen et al., 2017).
Various other endocrine inputs can stimulate the 
hepatic vagus or spinal afferents. Generally, the vagus 
acts in satiety and promotes gluconeogenesis, while the 
spinal nerves act in scarcity and promote glycogenolysis 
( Jensen et al., 2013; Streba et al., 2014; Yi et al., 2010). 
Interleukin-1, for example, is a cytokine that reduces 
feeding behavior during illness and acts through hepatic 
vagal stimulation (Berthoud, 2004; Jensen et al., 2013; Yi 
et al., 2010). Other interleukins may signal hepatocytes 
to produce immune proteins ( Jensen et al., 2013; Streba 
et al., 2014). Vagal afferents have also been shown to 
respond to cholecystokinin (CCK) released from I cells 
in the duodenum ( Jensen et al., 2013). This hormone 
reduces hepatic glucose production and is inhibited by 
a high-fat diet. While the hypothalamus plays a role 
in both pathways due to their endocrine nature, even 
a denervated liver can still express these functions (Yi 
et al., 2010). In liver transplant patients, for example, 
the majority of functions are preserved (Tiniakos et 
al., 1996; Yi et al., 2010). Yet it should be noted that 
a complete denervation is superior to an imbalance, 
and that completely denervated patients have the most 
trouble mobilizing large stores of glucose in the case of 
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Liver Innervation and Blood Flow
The influence of the autonomic nervous system upon 
hepatic function extends beyond metabolism to include 
the regulation of blood flow and solute concentration 
(Forssmann & Ito, 1977; Tiniakos et al., 1996). The 
liver is a heavily supplied organ, and in the event of an 
imbalance, it acts to maintain plasma homeostasis in 
response to autonomic innervation. This function makes 
the liver an extremely valuable peripheral osmoreceptor. 
The well-innervated walls of the hepatic blood vessels 
can trigger a pressor reflex in which sympathetic efferent 
stimulate the vessels to constrict and raise blood pressure 
( Jensen et al., 2013; Streba et al., 2014). This activity is 
mediated by afferent osmoreceptors such as transient 
receptor channel protein vanilloid 4 (TRPV4), which 
senses hypoosmotic environments through changes 
in ion current. The pressor reflex is impaired in liver 
transplant patients that cannot receive the influx of 
norepinephrine from adrenergic innervation ( Jensen et 
al., 2013; Kandilis et al., 2015; Mizuno & Ueno, 2017). 
Another reflex mediated by hepatic innervation is the 
hepatorenal reflex, a form of communication between 
the portal vein and the kidneys. The portal vein is well-
suited to sensing changes in plasma ion content because 
the concentration of dissolved solutes in the portal vein 
is much higher than in systemic circulation ( Jensen et al., 
2013; Mizuno & Ueno, 2017). If the portal vein senses 
an increase in the concentration of sodium ions portal 
innervation acts to dampen sympathetic stimulation of 
the kidneys. This innervation leads to increased Na+ 
excretion and restores ionic balance ( Jensen et al., 2013).
The large amount of blood funneled into the liver also 
makes the liver a key target in the case of hemorrhage. 
When a large amount of blood is lost from circulation, 
the body turns to the vast blood supply of the liver as 
a counterregulatory mechanism (Gardemann et al., 
1992; Jensen et al., 2013). Sympathetic innervation 
of the hepatic artery and its branches stimulates 
vasoconstriction, reducing blood flow to the liver in 
times of crisis (Beckh et al., 1990; Gardemann et al., 
1992; Jensen et al., 2013; Mizuno & Ueno, 2017). This 
process is highly dependent upon endothelin, with TLA 
and TLB1 receptors inducing the contraction of the 
smooth muscle (Streba et al., 2014). Higher mammals 
possessing aminergic innervation of the spaces of disse 
also experience contraction of the sinusoids (Burt et 
al., 1989; Gardemann et al., 1992; Jensen et al., 2013; 
Mizuno & Ueno, 2017). This process expels blood 
into the systemic circulation to restore blood volume 
and is mediated by catecholamines and substance P 
(Gardemann et al., 1992; Jensen et al., 2013). When 
the crisis has passed, vagal innervation works to relax 
the sinusoids (Gardemann et al., 1992; Jensen et al., 
2013). Acetylcholine and vasoactive intestinal peptide 
induce relaxation and allow the liver to resume its 
normal filtration of the blood (Gardemann et al., 1992; 
Jensen et al., 2013; Streba et al., 2014). Liver transplant 
patients, who lack these regulatory controls, are at high 
risk for hypovolemic shock due to reduced portal flow 
(Gardemann et al., 1992; Jensen et al., 2013; Kandilis 
et al., 2015). In fact, application of norepinephrine and 
epinephrine to a denervated liver results in an arterial 
buffer phenomenon, where portal flow is lost and hepatic 
artery flow increases (Gardemann et al., 1992; Jensen et 
al., 2013; Kandilis et al., 2015).
Liver Innervation and Bile Secretion
The liver’s network of bile ducts is innervated in 
many species, although usually in conjunction with 
nearby blood vessels. Therefore, hepatic autonomic 
innervation has an extensive impact on the flow and 
secretion of bile through the biliary system. Specialized 
epithelial cells, known as cholangiocytes, modify bile 
through the absorbance and secretion of bile salts and 
bicarbonate. These, in turn, are under sympathetic and 
parasympathetic control (Baik et al., 2017; Mizuno 
& Ueno, 2017). Cholinergic action is mediated by 
M3 cholinergic receptors on the cholangiocytes, and 
stimulation of these induces cholangiocyte proliferation 
and an increase in secretion of bicarbonate (Mizuno & 
Ueno, 2017).
Cholangiocytes also possess α and β adrenergic 
innervation, with the α-1 and α-2 receptors functioning 
antagonistically to one another (Mizuno & Ueno, 2017). 
The α1-adrenergic receptor pathway normally decreases 
ductal secretion, but this function can be reversed by 
exposure to phenylephrine, a factor that also promotes 
cholangiocyte proliferation ( Jensen et al., 2013). 
By comparison, α2-adrenergic receptor stimulation 
down-regulates the Gαq pathway responsible for 
aiding phenylephrine-induced proliferation ( Jensen 
et al., 2013). The antagonism of these two pathways is 
temporarily interrupted in the event of biliary injury, 
when both cooperate to increase expression of cyclical 
adenosine monophosphate (cAMP) and protein kinase 
B (Akt) to hasten the repair process ( Jensen et al., 2013). 
In addition to the adrenergic sympathetic pathways, the 
cholangiocytes also respond to a dopaminergic pathway 
11.2: 18-31
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that functions similarly to α2 stimulation ( Jensen et al., 
2013).
Cirrhotic Livers and Neuronal Regulation of Tissue 
Regeneration
The sympathetic nervous system has been shown to be 
both beneficial and disruptive to the repair of cirrhotic 
liver injury (Baik et al., 2017). Sympathetic innervation 
exerts its influence through the regulation of hepatic 
stellate cells (HSC) and oval cells (HOC) ( Jensen et 
al., 2013). HSCs are normally responsible for producing 
extracellular matrix and storing vitamin A ( Jensen et 
al., 2013; Streba et al., 2014). However, in the event of 
liver damage, these proliferate as myofibroblasts and 
synthesize collagen ( Jensen et al., 2013). While this 
function itself is not necessarily harmful, a buildup 
of collagenous scar tissue can eventually impair liver 
function and cause abnormal regrowth, a cycle of 
continued damage demonstrated in Figure 3 ( Jensen et 
al., 2013; Mizuno & Ueno, 2017). HSCs are stimulated 
by aminergic innervation and may also aid their own 
proliferation by secreting catecholamines themselves 
(Figure 3) ( Jensen et al., 2013).
This activity is responsible for the initial spike in 
catecholamines documented soon after liver damage, 
even though the growth nodules themselves tend to be 
denervated ( Jensen et al., 2013; Kiba, 2002; Lee et al., 
1992; Tiniakos et al., 1996). The proliferation of HSCs 
combined with aminergic stimulation blocks the growth 
of HOCs, which are necessary for the regeneration of 
hepatocytes (Figure 3) ( Jensen et al., 2013; Kandilis et 
al., 2015). Much of the abnormal growth seen in cirrhotic 
livers is thought to be caused by the impairment of these 
cells ( Jensen et al., 2013). Sympathetic stimulation 
also tends to exacerbate the damage by reducing blood 
supply to the liver ( Jensen et al., 2013; Kiba, 2002). Thus, 
inhibition of the hepatic sympathetic fibers may be a 
potential treatment for cirrhosis in the future ( Jensen et 
al., 2013).
Pathogenesis occurs through a cycle of damage and 
sympathetic response. Initial trauma leads to a surge 
in catecholamines, which causes the proliferation of 
stellate cells and inhibits oval cells. Stellate cells produce 
collagenous scar tissue, leading to abnormal regrowth. 
Constriction of the hepatic artery leads to further 
damage, and the cycle continues. Patients are at risk for 
developing hepatocellular carcinoma if abnormal growth 
persists (Baik et al., 2017; Jensen et al., 2013; Kandilis et 
al., 2015; Kiba, 2002; Mizuno & Ueno, 2017).
The parasympathetic nervous system influences liver 
regeneration through the hepatic thymidine kinase 
and aspartate transcarbamoylase pathways ( Jensen et 
11.2: 18-31
Figure 3: Sympathetic stimulation leads to abnormal regeneration in cirrhotic livers.
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al., 2013). Loss of subdiaphragmatic vagal innervation 
impairs liver regeneration, but this connection is 
confounded by other factors such as reduced food 
intake and impaired gastric emptying (Kiba, 2002). 
A ventromediolateral hypothalamic lesion, which 
increases vagal activity, was shown to have the opposite 
effect, increasing hepatic regeneration (Kiba, 2002). The 
hypothalamus plays a role in mediating liver apoptosis. 
Though the details of this role are somewhat ambiguous, 
the hypothalamus is thought to have an impact on 
cholinergic innervation (Kiba, 2002).
Liver innervation may not only be regulatory to tissue 
regeneration, but also necessary for it (Mizuno & Ueno, 
2017). Studies have shown that regeneration of the rat 
liver is possible as long as the fibers of the porta hepatis 
remain intact (Kiba, 2002). Furthermore, in observations 
of advanced cirrhosis and hepatocellular carcinoma, the 
infiltration of sympathetic innervation and subsequent 
stimulation of α1 adrenergic receptors on Kupffer cells 
were shown to promote carcinogenesis (Huan et al., 
2017). Kupffer cells release Interleukin-6 (IL-6) and 
transforming growth factor β (TGF-β), both of which 
are associated with poor prognosis in hepatocellular 
carcinoma patients (Boilly, Faulkner, Jobling, & 
Hondermarck, 2017; Huan et al., 2017). Sympathetic 
denervation improved the prognosis significantly, and 
evidence from other studies indicates neural-immune 
interplay in the generation of tumors (Boilly et al., 
2017; Huan et al., 2017). Carcinogenesis displays many 
similarities with epimorphic regeneration of limbs and 
organs (Boilly et al., 2017). Both processes require the 
invasion of macrophages, induction of inflammation 
by interleukins, and secretion of growth factors, all of 
which are aided by sympathetic innervation (Boilly et al., 
2017; Streba et al., 2014). In many aggressive cancers, 
tumor cells secrete neurotrophic growth factor (NGF) 
to promote axonogenesis and the innervation of the 
tumor tissue (Boilly et al., 2017). This benefits the cancer 
in two ways. First, innervation stimulates β-adrenergic 
and muscarinic receptors expressed by cancer cells, 
inducing rapid and aggressive proliferation (Boilly et al., 
2017). Second, access to a neural trunk allows cancers to 
metastasize (Boilly et al., 2017). Therefore, denervations, 
especially sympathetic denervations, are considered new 
targets for cancer therapy (Boilly et al., 2017; Huan et 
al., 2017). The critical role liver innervation plays in 
both normal and abnormal tissue growth cannot be 
discounted.
Other Liver Diseases and their Impacts
While cirrhosis is a highly prevalent liver condition that 
has been shown to have both structural and functional 
impacts upon the organ, other maladies of the liver have 
also been shown to present alterations in liver neural 
structure. Among these are hepatitis B and C (Baik et 
al., 2017). Both conditions reduce liver innervation as 
well as the production of S100B mRNA (Baik et al., 
2017). S100B is a calcium-binding protein found in 
the cytoplasm of glial cells and serves as an indicator 
for portal innervation (Baik et al., 2017). An absence of 
S100B-coding RNA indicates a loss of innervation, and 
this trend has also been reported for liver cirrhosis as well 
as hepatocellular carcinoma (Baik et al., 2017; Kandilis 
et al., 2015). This observation may seem counterintuitive, 
as innervation is critical to the degeneration of these 
conditions, and indeed various studies have found that 
there is an increase in hepatic innervation present, 
but both sides of this debate have reported similar 
problems with accurate quantification (Baik et al., 2017). 
Regardless of form, the abnormal growth of nodules, 
tumors, and other structural features of disease results in 
abnormal innervation. As with cirrhosis, fibrotic growth 
of the HSCs is speculated to be a contributing factor 
to liver denervation in other conditions, but evidence 
shows that once mRNA expression is altered, it becomes 
independent of further fibrosis (Baik et al., 2017).
DISCUSSION
This paper has offered an overview of the current literature 
surrounding the anatomy and physiology of autonomic 
innervation of the liver and has explored the interaction 
between the CNS and hepatic tissue to maintain 
homeostasis and regulate metabolism. However, this 
review would be incomplete without an analysis of the 
issues that remain unresolved, as well as the directions 
future studies may take to answer these questions. 
First, it is worth noting that much of the information 
contained in this review was drawn from studies that are 
many years, even decades old. There thus exists a lack 
of recent literature regarding hepatic innervation. The 
paucity of information concerning the liver-brain axis 
would suggest one of two possibilities: either that limited 
progress has been made, or that the discouraging lack of 
knowledge regarding the topic has sidelined it in favor 
of other targets. In either case, the fact that relatively 
little recent literature exists means that much of the 
current knowledge surrounding liver innervation is in 
dire need of an update. Study of these topics was likely 
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limited by the technology of the past, but with modern 
advances in microscopy, tissue sectioning, and labelling, 
new studies could be undertaken to not only validate the 
predecessors but also discover new information. Among 
the most important issues to be addressed are the elusive 
intrahepatic ganglia. The idea that an organ as large, 
complex, and critical as the liver would lack such vital 
neural structures seems absurd, yet no such formation 
has been found to date (Berthoud, 2004; Berthoud and 
Neuhuber, 2000; Taher et al., 2017). An inability to find 
a structure is hardly compelling evidence that it is not 
present at all, especially given the dated methods used 
before. Thus, the search for intrahepatic ganglia must be 
continued.
The physiology of liver innervation has more gaps 
in the literature than the anatomy of the neurons 
themselves. More specifically, the current knowledge 
understands “what” sympathetic and vagal stimulation 
of hepatic tissue is likely responsible for, but “how” the 
mechanisms operate is largely unknown. For example, 
there is a suspected parasympathetic pathway of NPY 
function, but so far only the sympathetic arm has been 
elucidated in appreciable detail (Kalsbeek et al., 2010; 
Smith, 2018). TRH is known to induce hyperglycemia, 
but the mechanism behind this blood sugar spike is not 
available (Kalsbeek et al., 2010). This mechanism could 
be neural or endocrine, and involve autonomic pathways 
from the CNS, but only further study will be able to say 
for certain. Perhaps the strangest and most puzzling 
problem of all is how the liver functions without CNS 
innervation. Liver transplant patients have hepatic 
tissues that operate almost normally (Tiniakos, Lee, & 
Burt, 1996; Yi et al., 2010). If the liver-brain axis is as 
vital as some data suggest, why are denervated livers able 
to perform most of the same actions a normal liver can? 
The ambiguity surrounding the anatomy, function, and 
necessity of hepatic autonomic innervation makes this 
area a vital field of future study.
If any scientific progress is to be made toward a more 
complete understanding of liver innervation, more 
powerful, accurate, and thorough screening and 
denervation technologies must be brought to bear. Tracers 
such as calretinin and P2X2/X3 vesicular glutamate 
transporter have potential (Berthoud, 2004), but have 
been used to label liver tissue in few, if any, laboratory 
trials. Of even greater importance is the need for a 
reliable way to obliterate certain populations of hepatic 
neurons without harming unrelated nerves. This method 
would allow the functions of specific groups of neurons 
to be isolated according to type, origin, and secretions. 
Chemical and biological agents that specifically target 
sympathetic hepatic neurons may be especially important 
for treating liver cirrhosis and cancer, since sympathetic 
stimulation is partly responsible for the progression 
of these diseases (Baik et al., 2017; Huan et al., 2017; 
Jensen et al., 2013). Such technologies are within our 
capacity to develop and doing so will reveal the location 
of intrahepatic ganglia as well as elucidate the various 
CNS pathways that are currently incomplete.
CONCLUSION
The connection between the liver and the central 
nervous system is a vastly under-studied arena with 
various unknown structures, functions, and mechanisms 
(Akiyoshi et al., 1998; Berthoud, 2004; Kalsbeek et al., 
2010; McCuskey, 2004; Perez-Tilve et al., 2010; Taher et 
al., 2017; Verma et al., 2018; Yi et al., 2010). A large part 
of this knowledge gap is due to the inability of previous 
technologies to properly isolate and map liver innervation 
(Berthoud, 2004; Yi et al., 2010). As biomedical sciences 
continue to advance and our understanding of the 
neural structure and function of the liver improves, these 
questions may be answered, thereby revealing more of 
the widespread impact of autonomic hepatic innervation 
in both normal physiology and disease states. Such an 
under-studied yet critically important organ provides an 
exciting frontier for continued research and the potential 
for intriguing new discoveries. This paper provides a brief 
analysis of past and current data, taking special note of 
areas that require a great deal of further study. Revisiting 
the issue of autonomic influence upon hepatic function 
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